Consolidated Condensed Statements Of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jan. 31, 2016	Jan. 31, 2015
Capital Expenditures Incurred but Not yet Paid	$ 4,425	$ 4,016
Non-cash capital expenditures under long-term financing	0	7,037
Cash flows from operating activities:
Net income (loss)	57,201	51,376
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	79,241	73,345
Cost of real estate sales	9,444	12,620
Stock-based compensation expense	8,390	8,226
Deferred income taxes, net	35,937	24,321
Change in Fair Value of Contingent Consideration	0	(4,550)
Gain (Loss) Related to Litigation Settlement	0	(16,400)
Park City litigation payment to Talisker	0	(10,000)
Other non-cash income, net	(2,134)	(2,577)
Increase (Decrease) in Restricted Cash	(6,894)	(311)
Changes in assets and liabilities:
Trade receivables, net	27,696	28,742
Inventories, net	(5,263)	(5,358)
Accounts payable and accrued liabilities	111,778	129,655
Other assets and liabilities, net	(19,716)	(15,526)
Net cash provided by operating activities	309,468	274,185
Cash flows from investing activities:
Capital expenditures	(77,237)	(74,020)
Acquisition of businesses	(20,245)	(182,500)
Other investing activities, net	3,961	704
Net cash used in investing activities	(93,521)	(255,816)
Proceeds from Issuance of Other Long-term Debt	105,000	243,000
Line of Credit Facility, Periodic Payment	225,500	243,000
Repayments of Term Loan	(3,125)	0
Repayments of Long-term Debt	(257)	(536)
Cash flows from financing activities:
Dividends paid	(45,221)	(30,141)
Payments for Repurchase of Common Stock	(40,000)	0
Other financing activities, net	3,925	4,593
Net cash used in financing activities	(205,178)	(26,084)
Effect of exchange rate changes on cash and cash equivalents	(860)	(113)
Net decrease in cash and cash equivalents	9,909	(7,828)
Cash and cash equivalents:
Beginning of period	35,459	44,406
End of period	$ 45,368	$ 36,578